1. Home
  2. FTHM vs MRKR Comparison

FTHM vs MRKR Comparison

Compare FTHM & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fathom Holdings Inc.

FTHM

Fathom Holdings Inc.

HOLD

Current Price

$0.82

Market Cap

31.5M

Sector

Finance

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.44

Market Cap

27.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTHM
MRKR
Founded
2010
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.5M
27.7M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
FTHM
MRKR
Price
$0.82
$1.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$2.50
$10.00
AVG Volume (30 Days)
154.9K
124.5K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
32.71
33.61
EPS
N/A
N/A
Revenue
$420,477,000.00
N/A
Revenue This Year
$11.67
N/A
Revenue Next Year
N/A
$936.27
P/E Ratio
N/A
N/A
Revenue Growth
25.45
N/A
52 Week Low
$0.48
$0.81
52 Week High
$3.37
$4.07

Technical Indicators

Market Signals
Indicator
FTHM
MRKR
Relative Strength Index (RSI) 43.57 44.02
Support Level $0.70 $1.34
Resistance Level $0.85 $1.43
Average True Range (ATR) 0.10 0.09
MACD -0.02 -0.01
Stochastic Oscillator 1.31 15.60

Price Performance

Historical Comparison
FTHM
MRKR

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: MT-601; and MT-401-OTS.

Share on Social Networks: